Delisting risk
Cognition Therapeutics
Developing zervimesine for Lewy body dementia psychosis.
$1.04
After-hours close+0.02 (+1.99%)
At close$1.02(−3.77%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.07 | — | — |
| Aug 2026 | −$0.06 | −$0.04 | +36.8% |
| May 2026 | −$0.06 | −$0.05 | +16.7% |
| Mar 2026 | −$0.06 | −$0.02 | +66.7% |
| Nov 2025 | −$0.07 | −$0.06 | +14.3% |
The latest year is open to everyone — the 22 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Oct 2021 | |||
| Mar 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 5, 2026 | −$0.07 | — | — | $5.3M | — | — |
| Aug 6, 2026 | −$0.06 | −$0.04 | +36.8% | $5.0M | — | — |
| May 7, 2026 | −$0.06 | −$0.05 | +16.7% | $4.4M | — | — |
| Mar 26, 2026 | −$0.06 | −$0.02 | +66.7% | — | — | — |
| Nov 6, 2025 | −$0.07 | −$0.06 | +14.3% | — | — | — |
The latest year is open to everyone — the 22 quarters behind it read with an account. Sign in | ||||||
| Aug 7, 2025 | ||||||
| May 7, 2025 | ||||||
| Mar 20, 2025 | ||||||
| Nov 13, 2024 | ||||||
| Aug 8, 2024 | ||||||
| May 7, 2024 | ||||||
| Mar 26, 2024 | ||||||
| Nov 2, 2023 | ||||||
| Aug 8, 2023 | ||||||
| May 4, 2023 | ||||||
| Mar 23, 2023 | ||||||
| Nov 14, 2022 | ||||||
| Aug 9, 2022 | ||||||
| May 11, 2022 | ||||||
| Mar 30, 2022 | ||||||
| Nov 17, 2021 | ||||||
| Oct 8, 2021 | ||||||
| Mar 31, 2021 | ||||||
| Dec 31, 2020 | ||||||
| Sep 30, 2020 | ||||||
| Jun 30, 2020 | ||||||
| Mar 31, 2020 | ||||||